Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
23h
Exelixis Hold Rating: Navigating Legal Wins and Strategic Acquisitions Amid Uncertain Revenue Transition
Exelixis (EXEL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Stephen Willey ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
One Direction singer dies
Gets minimum 28 years
Revives Fox News lawsuit
US adults loneliness survey
US Navy aircraft crashes
Exotic cat caught in suburb
$750M US chips grant
SpaceX sues CA regulators
Parents sue MA school
'Click to cancel' finalized
New cervical cancer regimen
PA gun restrictions ruling
To headline Atlanta rally
Ordered to pay $15 million
Salton Sea conservation
To return to Atlanta in 2028
Disney to debut new pass
MI shooter drill settlement
Had benign cyst removed
Italy expands surrogacy ban
$1.4B renovation deal OK'd
Must face US state lawsuits
Felon voting rights upheld
Cereal dyes protested
To invest in nuclear reactors
Broadband data caps probe
Synthetic nicotine pouches
Abortion group sues Florida
To cut up to 2,500 jobs
To settle US bribery probe
FDA halts Novavax trial
Related topics
Exelixis
Merck & Co.
WELIREG
Pembrolizumab
Phases of clinical research
Feedback